Fabrice PIROT
Equipe : Groupe Rockfeller
Courriel : fabrice.pirot@univ-lyon1.fr
Téléphone : +33(0)4-78-78-56-86
Statut : Professeur
8 publications au total. Seules les 5 dernières années sont affichées
2017
8. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.
Boisgard As, Lamrayah M, Dzikowski M, Salmon D, Kirilov P, Primard C, Pirot F, Fromy B, Verrier B
(2017) Eur J Pharm Biopharm 116 :51-60
7. Comparison of four different fuller's earth formulations in skin decontamination.
Roul A, Le Ca, Gustin Mp, Clavaud E, Verrier B, Pirot F, Falson F
(2017) J Appl Toxicol :
2016
6. Percutaneous absorption of benzophenone-3 loaded lipid nanoparticles and polymeric nanocapsules: A comparative study.
Gilbert E, Roussel L, Serre C, Sandouk R, Salmon D, Kirilov P, Haftek M, Falson F, Pirot F
(2016) Int J Pharm 504 :48-58
5. Ex-Vivo percutaneous absorption of enrofloxacin: Comparison of LMOG organogel vs. pentravan cream.
Kirilov P, Tran Vh, Ducrotte-tassel A, Salvi Jp, Perrot S, Haftek M, Boulieu R, Pirot F
(2016) Int J Pharm 498 :170-7
2015
4. Deleterious effects of skin freezing contribute to variable outcomes of the predictive drug permeation studies using hydrophilic molecules.
Abdayem R, Roussel L, Zaman N, Pirot F, Gilbert E, Haftek M
(2015) Exp Dermatol 24 :972-4
3. Measurement, analysis and prediction of topical UV filter bioavailability.
Roussel L, Gilbert E, Salmon D, Serre C, Gabard B, Haftek M, Maibach Hi, Pirot F
(2015) Int J Pharm 478 :804-10
2. New easy handling and sampling device for bioavailability screening of topical formulations.
Salmon D, Gilbert E, Gioia B, Haftek M, Pivot C, Verrier B, Pirot F
(2015) Eur J Dermatol 25 Suppl 1 :23-9
1. [Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study].
Tall Ml, Lehmann S, Diouf E, Gerard C, Filali S, Gabelle A, Hirtz C, Gabert L, Sauvinet V, Pirot F, Pivot C
(2015) Ann Pharm Fr 73 :43-59
